|
1
|
Lemke G: Molecular biology of the major
myelin genes. Trends Neurosciences. 9:266–270. 1986. View Article : Google Scholar
|
|
2
|
Sutcliffe JG: The genes for myelin
revisited. Trends Genet. 4:211–213. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patzig J, Jahn O, Tenzer S, Wichert SP, de
Monasterio-Schrader P, Rosfa S, Kuharev J, Yan K, Bormuth I, Bremer
J, et al: Quantitative and integrative proteome analysis of
peripheral nerve myelin identifies novel myelin proteins and
candidate neuropathy loci. J Neurosci. 31:16369–16386. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warner LE, Hilz MJ, Appel SH, Killian JM,
Kolodry EH, Karpati G, Carpenter S, Watters GV, Wheeler C, Witt D,
et al: Clinical phenotypes of different MPZ (P0) mutations may
include charcot-marie-tooth type 1B, dejerine-sottas, and
congenital hypomyelination. Neuron. 17:451–460. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mandich P, Mancardi GL, Varese A, Soriani
S, Di Maria E, Bellone E, Bado M, Gross L, Windebank AJ, Ajmar F
and Schenone A: Congenital hypomyelination due to myelin protein
zero Q215X mutation. Ann Neurol. 45:676–678. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Murakami T, Garcia CA, Reiter LT and
Lupski JR: Charcot-marie-tooth disease and related inherited
neuropathies. Medicine (Baltimore). 75:233–250. 1996. View Article : Google Scholar
|
|
7
|
Wrabetz L, D'Antonio M, Pennuto M, Dati G,
Tinelli E, Fratta P, Previtali S, Imperiale D, Zielasek J, Toyka K,
et al: Different intracellular pathomechanisms produce diverse
myelin protein zero neuropathies in transgenic mice. J Neurosci.
26:2358–2368. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tobler AR, Notterpek L, Naef R, Taylor V,
Suter U and Shooter EM: Transport of Trembler-J mutant peripheral
myelin protein 22 is blocked in the intermediate compartment and
affects the transport of the wild-type protein by direct
interaction. J Neurosci. 19:2027–2036. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sancho S, Young P and Suter U: Regulation
of Schwann cell proliferation and apoptosis in PMP22-deficient mice
and mouse models of charcot-marie-tooth disease type 1A. Brain.
124:2177–2187. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khajavi M, Inoue K, Wiszniewski W, Ohyama
T, Snipes GJ and Lupski JR: Curcumin treatment abrogates
endoplasmic reticulum retention and aggregation-induced apoptosis
associated with neuropathy-causing myelin protein zero-truncating
mutants. Am J Hum Genet. 77:841–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Myers JK, Mobley CK and Sanders CR: The
peripheral neuropathy-linked trembler and trembler-J mutant forms
of peripheral myelin protein 22 are folding-destabilized.
Biochemistry. 47:10620–10629. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sakakura M, Hadziselimovic A, Wang Z,
Schey KL and Sanders CR: Structural basis for the trembler-J
phenotype of charcot-marie-tooth disease. Structure. 19:1160–1169.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rutkowski DT and Kaufman RJ: A trip to the
ER: Coping with stress. Trends Cell Biol. 14:20–28. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Welihinda AA and Kaufman RJ: The unfolded
protein response pathway in Saccharomyces cerevisiae.
Oligomerization and trans-phosphorylation of Ire1p (Ern1p) are
required for kinase activation. J Biol Chem. 271:18181–18187. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hetz C and Mollereau B: Disturbance of
endoplasmic reticulum proteostasis in neurodegenerative diseases.
Nat Rev Neurosci. 15:233–249. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mitchison DA: Role of individual drugs in
the chemotherapy of tuberculosis. Int J Tuberc Lung Dis. 4:796–806.
2000.PubMed/NCBI
|
|
17
|
Daniel F, Seksik P, Cacheux W, Jian R and
Marteau P: Tolerance of 4-aminosalicylic acid enemas in patients
with inflammatory bowel disease and 5-aminosalicylic-induced acute
pancreatitis. Inflamm Bowel Dis. 10:258–260. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Joshi R, Kumar S, Unnikrishnan M and
Mukherjee T: Free radical scavenging reactions of sulfasalazine,
5-aminosalicylic acid and sulfapyridine: Mechanistic aspects and
antioxidant activity. Free Radic Res. 39:1163–1172. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patole J, Shingnapurkar D, Padhye S and
Ratledge C: Schiff base conjugates of p-aminosalicylic acid as
antimycobacterial agents. Bioorg Med Chem Lett. 16:1514–1517. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoon H, Lee GH, Kim DS, Kim KW, Kim HR and
Chae HJ: The effects of 3, 4 or 5 amino salicylic acids on
manganese-induced neuronal death: ER stress and mitochondrial
complexes. Toxicol In Vitro. 25:1259–1268. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saporta MA, Shy BR, Patzko A, Bai Y,
Pennuto M, Ferri C, Tinelli E, Saveri P, Kirschner D, Crowther M,
et al: MpzR98C arrests Schwann cell development in a mouse model of
early-onset charcot-marie-tooth disease type 1B. Brain.
135:2032–2047. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grandis M, Vigo T, Passalacqua M, Jain M,
Scazzola S, La Padula V, Brucal M, Benvenuto F, Nobbio L, Cadoni A,
et al: Different cellular and molecular mechanisms for early and
late-onset myelin protein zero mutations. Hum Mol Genet.
17:1877–1889. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pennuto M, Tinelli E, Malaguti M, Del
Carro U, D'Antonio M, Ron D, Quattrini A, Feltri ML and Wrabetz L:
Ablation of the UPR-mediator CHOP restores motor function and
reduces demyelination in charcot-marie-tooth 1B mice. Neuron.
57:393–405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haynes CM, Titus EA and Cooper AA:
Degradation of misfolded proteins prevents ER-derived oxidative
stress and cell death. Mol Cell. 15:767–776. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xue X, Piao JH, Nakajima A, Sakon-Komazawa
S, Kojima Y, Mori K, Yagita H, Okumura K, Harding H and Nakano H:
Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein
response (UPR) in a reactive oxygen species (ROS)-dependent
fashion, and the UPR counteracts ROS accumulation by TNFalpha. J
Biol Chem. 280:33917–33925. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Williams C, Panaccione R, Ghosh S and
Rioux K: Optimizing clinical use of mesalazine (5-aminosalicylic
acid) in inflammatory bowel disease. Therap Adv Gastroenterol.
4:237–248. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fox W, Ellard GA and Mitchison DA: Studies
on the treatment of tuberculosis undertaken by the british medical
research council tuberculosis units 1946 1986 with relevant
subsequent publications. Int J Tuberc Lung Dis. 3(Suppl 2): pp.
S231–S279. 1999
|
|
28
|
Urano F, Wang X, Bertolotti A, Zhang Y,
Chung P, Harding HP and Ron D: Coupling of stress in the ER to
activation of JNK protein kinases by transmembrane protein kinase
IRE1. Science. 287:664–666. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cao SS and Kaufman RJ: Endoplasmic
reticulum stress and oxidative stress in cell fate decision and
human disease. Antioxid Redox Signal. 21:396–413. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fukumura H, Sato M, Kezuka K, Sato I, Feng
X, Okumura S, Fujita T, Yokoyama U, Eguchi H, Ishikawa Y and Saito
T: Effect of ascorbic acid on reactive oxygen species production in
chemotherapy and hyperthermia in prostate cancer cells. J Physiol
Sci. 62:251–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peng Y, Kwok KH, Yang PH, Ng SS, Liu J,
Wong OG, He ML, Kung HF and Lin MC: Ascorbic acid inhibits ROS
production, NF-kappa B activation and prevents ethanol-induced
growth retardation and microencephaly. Neuropharmacology.
48:426–434. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shy ME, Jáni A, Krajewski K, Grandis M,
Lewis RA, Li J, Shy RR, Balsamo J, Lilien J, Garbern JY and Kamholz
J: Phenotypic clustering in MPZ mutations. Brain. 127:371–384.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Patzko A, Bai Y, Saporta MA, Katona I, Wu
X, Vizzuso D, Feltri ML, Wang S, Dillon LM, Kamholz J, et al:
Curcumin derivatives promote schwann cell differentiation and
improve neuropathy in R98C CMT1B mice. Brain. 135:3551–3566. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Okamoto Y, Pehlivan D, Wiszniewski W, Beck
CR, Snipes GJ, Lupski JR and Khajavi M: Curcumin facilitates a
transitory cellular stress response in trembler-J mice. Hum Mol
Genet. 22:4698–4705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Egan ME, Pearson M, Weiner SA, Rajendran
V, Rubin D, Glockner-Pagel J, Canny S, Du K, Lukacs GL and Caplan
MJ: Curcumin, a major constituent of turmeric, corrects cystic
fibrosis defects. Science. 304:600–602. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vasireddy V, Chavali VR, Joseph VT, Kadam
R, Lin JH, Jamison JA, Kompella UB, Reddy GB and Ayyagari R: Rescue
of photoreceptor degeneration by curcumin in transgenic rats with
P23H rhodopsin mutation. PLoS One. 6:e211932011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y, Xiao J, Zhou H, Yang S, Wu X,
Jiang C, Zhao Y, Liang D, Li X and Liang G: A novel monocarbonyl
analogue of curcumin, (1E,4E)-1,5-bis(2,3-dimethoxyphenyl)
penta-1,4-dien-3-one, induced cancer cell H460 apoptosis via
activation of endoplasmic reticulum stress signaling pathway. J Med
Chem. 54:3768–3778. 2011. View Article : Google Scholar : PubMed/NCBI
|
